These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23845482)

  • 1. Development of a rapid method for the simultaneous separation and determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its N- and O-glucuronides in human urine by liquid chromatography-tandem mass spectrometry.
    Yao L; Zheng S; Guan Y; Yang J; Liu B; Wang W; Zhu X
    Anal Chim Acta; 2013 Jul; 788():61-7. PubMed ID: 23845482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct analysis of tobacco-specific nitrosamine NNK and its metabolite NNAL in human urine by LC-MS/MS: evidence of linkage to methylated DNA lesions.
    Hu CW; Hsu YW; Chen JL; Tam LM; Chao MR
    Arch Toxicol; 2014 Feb; 88(2):291-9. PubMed ID: 24057573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.
    Carmella SG; Han S; Fristad A; Yang Y; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1257-61. PubMed ID: 14652291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine by extraction on a molecularly imprinted polymer column and liquid chromatography/atmospheric pressure ionization tandem mass spectrometry.
    Xia Y; McGuffey JE; Bhattacharyya S; Sellergren B; Yilmaz E; Wang L; Bernert JT
    Anal Chem; 2005 Dec; 77(23):7639-45. PubMed ID: 16316171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers.
    Carmella SG; Ming X; Olvera N; Brookmeyer C; Yoder A; Hecht SS
    Chem Res Toxicol; 2013 Aug; 26(8):1209-17. PubMed ID: 23837805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modified method for the determination of tobacco specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine by solid phase extraction using a molecularly imprinted polymer and liquid chromatography tandem mass spectrometry.
    Shah KA; Halquist MS; Karnes HT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(14-15):1575-82. PubMed ID: 19395323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
    Carmella SG; Borukhova A; Akerkar SA; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microfluidic direct injection method for analysis of urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) using molecularly imprinted polymers coupled on-line with LC-MS/MS.
    Shah KA; Peoples MC; Halquist MS; Rutan SC; Karnes HT
    J Pharm Biomed Anal; 2011 Jan; 54(2):368-78. PubMed ID: 20926216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a method for the determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine of nonsmokers and smokers using liquid chromatography/tandem mass spectrometry.
    Hou H; Zhang X; Tian Y; Tang G; Liu Y; Hu Q
    J Pharm Biomed Anal; 2012 Apr; 63():17-22. PubMed ID: 22366322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of an assay for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine for the assessment of tobacco-related harm.
    Lu W; Ferguson SG; Nichols DS; Patel R; Jacobson GA
    J Pharm Biomed Anal; 2016 Nov; 131():327-332. PubMed ID: 27632782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.
    Carmella SG; Le Ka KA; Upadhyaya P; Hecht SS
    Chem Res Toxicol; 2002 Apr; 15(4):545-50. PubMed ID: 11952341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid chromatographic/tandem mass spectrometric method for the determination of the tobacco-specific nitrosamine metabolite NNAL in smokers' urine.
    Byrd GD; Ogden MW
    J Mass Spectrom; 2003 Jan; 38(1):98-107. PubMed ID: 12526011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry.
    Jacob P; Havel C; Lee DH; Yu L; Eisner MD; Benowitz NL
    Anal Chem; 2008 Nov; 80(21):8115-21. PubMed ID: 18841944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers.
    Chen G; Luo S; Kozlovich S; Lazarus P
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1175-1184. PubMed ID: 27197298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development, validation and transfer of a hydrophilic interaction liquid chromatography/tandem mass spectrometric method for the analysis of the tobacco-specific nitrosamine metabolite NNAL in human plasma at low picogram per milliliter concentrations.
    Pan J; Song Q; Shi H; King M; Junga H; Zhou S; Naidong W
    Rapid Commun Mass Spectrom; 2004; 18(21):2549-57. PubMed ID: 15468159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new liquid chromatography/mass spectrometry method for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine.
    Bhat SH; Gelhaus SL; Mesaros C; Vachani A; Blair IA
    Rapid Commun Mass Spectrom; 2011 Jan; 25(1):115-21. PubMed ID: 21154658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tobacco-specific nitrosamines and their pyridine-N-glucuronides in the urine of smokers and smokeless tobacco users.
    Stepanov I; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):885-91. PubMed ID: 15824160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereochemistry of metabolites of a tobacco-specific lung carcinogen in smokers' urine.
    Carmella SG; Ye M; Upadhyaya P; Hecht SS
    Cancer Res; 1999 Aug; 59(15):3602-5. PubMed ID: 10446969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low ratio of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol-glucuronides (NNAL-Gluc)/free NNAL increases urothelial carcinoma risk.
    Chung CJ; Lee HL; Yang HY; Lin P; Pu YS; Shiue HS; Su CT; Hsueh YM
    Sci Total Environ; 2011 Apr; 409(9):1638-42. PubMed ID: 21334728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine.
    Carmella SG; Akerkar SA; Richie JP; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):635-42. PubMed ID: 8547830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.